tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TARS Stock Latest News

Tarsus Pharmaceuticals’ Earnings Call Highlights Success and Challenges
Company AnnouncementsTarsus Pharmaceuticals’ Earnings Call Highlights Success and Challenges
3d ago
TARS
Hold Rating for Tarsus Pharmaceuticals Amid Strong Sales and Market Uncertainties
PremiumRatings
Hold Rating for Tarsus Pharmaceuticals Amid Strong Sales and Market Uncertainties
4d ago
TARS
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
PremiumThe Fly
Guggenheim ups Tarsus Pharmaceuticals price target, would buy on weakness
4d ago
TARS
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
PremiumRatings
Tarsus Pharmaceuticals: Strong Earnings and Growth Potential Make It a Buy
4d ago
TARS
Tarsus Pharmaceuticals: Undervalued Growth Potential and Acquisition Appeal Reinforce Buy Rating
PremiumRatings
Tarsus Pharmaceuticals: Undervalued Growth Potential and Acquisition Appeal Reinforce Buy Rating
4d ago
TARS
Tarsus Pharmaceuticals price target lowered to $60 from $62 at Barclays
PremiumThe FlyTarsus Pharmaceuticals price target lowered to $60 from $62 at Barclays
4d ago
TARS
Tarsus Pharmaceuticals Reports Strong 2024 Financial Results
Premium
Company Announcements
Tarsus Pharmaceuticals Reports Strong 2024 Financial Results
5d ago
TARS
Tarsus Pharmaceuticals price target lowered to $70 from $75 at BofA
Premium
The Fly
Tarsus Pharmaceuticals price target lowered to $70 from $75 at BofA
5d ago
TARS
Tarsus Pharmaceuticals: Strong Buy Rating Driven by Impressive Financial Performance and Strategic Growth Positioning
PremiumRatings
Tarsus Pharmaceuticals: Strong Buy Rating Driven by Impressive Financial Performance and Strategic Growth Positioning
5d ago
TARS
Tarsus Pharmaceuticals reports Q4 EPS (60c), consensus (82c)
PremiumThe Fly
Tarsus Pharmaceuticals reports Q4 EPS (60c), consensus (82c)
5d ago
TARS
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals
PremiumRatings
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals
26d ago
TARS
Tarsus Pharmaceuticals price target raised to $62 from $60 at Barclays
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $62 from $60 at Barclays
1M ago
TARS
Tarsus Pharmaceuticals price target raised to $72 from $65 at Oppenheimer
PremiumThe FlyTarsus Pharmaceuticals price target raised to $72 from $65 at Oppenheimer
1M ago
TARS
Tarsus Pharmaceuticals provides 2025 update
Premium
The Fly
Tarsus Pharmaceuticals provides 2025 update
2M ago
TARS
Tarsus Pharmaceuticals price target raised to $41 from $36 at Goldman Sachs
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $41 from $36 at Goldman Sachs
4M ago
TARS
Tarsus Pharmaceuticals price target raised to $73 from $61 at H.C. Wainwright
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $73 from $61 at H.C. Wainwright
4M ago
TARS
Tarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
PremiumThe Fly
Tarsus Pharmaceuticals price target raised to $65 from $63 at Oppenheimer
4M ago
TARS
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
PremiumCompany Announcements
Tarsus Pharmaceuticals Reports Strong Q3 2024 Performance
4M ago
TARS
Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
PremiumThe Fly
Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
4M ago
NN
CNH
Tarsus Pharmaceuticals reports Q3 EPS (61c), consensus (94c)
PremiumThe FlyTarsus Pharmaceuticals reports Q3 EPS (61c), consensus (94c)
4M ago
TARS
Tarsus Pharmaceuticals appoints Goodrich to board of directors
Premium
The Fly
Tarsus Pharmaceuticals appoints Goodrich to board of directors
4M ago
TARS
TARS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
TARS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
TARS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >